SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kamron Laboratories submits newspaper clippings

20 Aug 2021 Evaluate

In furtherance to its letter dated 19th August 2021 submitting notice of AGM, Kamron Laboratories has informed that it enclosed clippings of Newspaper Advertisement published on 20th August, 2021. This is in due compliance of the relevant Regulations of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.





Adline Chem Lab Share Price

11.28 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×